Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C

Masaaki Kondo, Katsuaki Tanaka, Masanori Ikeda, Shinju Arata, Satoru Saito, Takashi Sakaguchi, Manabu Morimoto, Takando Fujii, Konomi Mitsui, Hiroshi Okazaki, Masato Hoshino, Hisahiko Sekihara

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Measurement of serum HCV-RNA is a useful index for evaluating the antiviral effect of interferon therapy in chronic hepatitis C. In the present study, we investigated whether the detection of hepatic HCV-RNA after interferon treatment, using a polymerase chain reaction assay, predicted long-term response to therapy in patients with chronic hepatitis C. Thirty-three patients underwent liver biopsies before and after interferon therapy. Histology and clinical courses were compared after treatment. Before therapy, serum and hepatic HCV-RNA was detected in specimens from 32 (97%) and 33 (100%) patients, respectively. Serum HCV-RNA became undetectable in samples from 22 (67%) patients; however, in 10 of these patients (45%), serum HCV-RNA levels relapsed after therapy. Hepatic HCV-RNA became undetectable in 14 patients after therapy and the serum aminotransferase concentration remained within normal limits during and following (24-92 weeks) therapy in 12 of these patients (86%). All 11 patients with detectable hepatic HCV-RNA also had serum HCV-RNA and elevated aminotransferase concentrations refractory to therapy. The absence of hepatic HCV-RNA at the end of interferon treatment thus predicted a long-term complete response to therapy with a sensitivity of 100%, a specificity of 90% and an accuracy of 94%. We conclude that hepatic rather than serum HCV-RNA is a more useful index for the prediction of the long-term efficacy of interferon therapy.

Original languageEnglish
Pages (from-to)236-240
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume11
Issue number3
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Chronic Hepatitis C
Interferons
RNA
Liver
Serum
Therapeutics
Transaminases
Antiviral Agents
Histology

Keywords

  • Chronic hepatitis C
  • Hepatic HCV-RNA
  • Interferon
  • PCR

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Kondo, M., Tanaka, K., Ikeda, M., Arata, S., Saito, S., Sakaguchi, T., ... Sekihara, H. (1996). Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology (Australia), 11(3), 236-240.

Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C. / Kondo, Masaaki; Tanaka, Katsuaki; Ikeda, Masanori; Arata, Shinju; Saito, Satoru; Sakaguchi, Takashi; Morimoto, Manabu; Fujii, Takando; Mitsui, Konomi; Okazaki, Hiroshi; Hoshino, Masato; Sekihara, Hisahiko.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 11, No. 3, 1996, p. 236-240.

Research output: Contribution to journalArticle

Kondo, M, Tanaka, K, Ikeda, M, Arata, S, Saito, S, Sakaguchi, T, Morimoto, M, Fujii, T, Mitsui, K, Okazaki, H, Hoshino, M & Sekihara, H 1996, 'Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C', Journal of Gastroenterology and Hepatology (Australia), vol. 11, no. 3, pp. 236-240.
Kondo, Masaaki ; Tanaka, Katsuaki ; Ikeda, Masanori ; Arata, Shinju ; Saito, Satoru ; Sakaguchi, Takashi ; Morimoto, Manabu ; Fujii, Takando ; Mitsui, Konomi ; Okazaki, Hiroshi ; Hoshino, Masato ; Sekihara, Hisahiko. / Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C. In: Journal of Gastroenterology and Hepatology (Australia). 1996 ; Vol. 11, No. 3. pp. 236-240.
@article{ec934dbbe90742768ebe3146cd72767e,
title = "Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C",
abstract = "Measurement of serum HCV-RNA is a useful index for evaluating the antiviral effect of interferon therapy in chronic hepatitis C. In the present study, we investigated whether the detection of hepatic HCV-RNA after interferon treatment, using a polymerase chain reaction assay, predicted long-term response to therapy in patients with chronic hepatitis C. Thirty-three patients underwent liver biopsies before and after interferon therapy. Histology and clinical courses were compared after treatment. Before therapy, serum and hepatic HCV-RNA was detected in specimens from 32 (97{\%}) and 33 (100{\%}) patients, respectively. Serum HCV-RNA became undetectable in samples from 22 (67{\%}) patients; however, in 10 of these patients (45{\%}), serum HCV-RNA levels relapsed after therapy. Hepatic HCV-RNA became undetectable in 14 patients after therapy and the serum aminotransferase concentration remained within normal limits during and following (24-92 weeks) therapy in 12 of these patients (86{\%}). All 11 patients with detectable hepatic HCV-RNA also had serum HCV-RNA and elevated aminotransferase concentrations refractory to therapy. The absence of hepatic HCV-RNA at the end of interferon treatment thus predicted a long-term complete response to therapy with a sensitivity of 100{\%}, a specificity of 90{\%} and an accuracy of 94{\%}. We conclude that hepatic rather than serum HCV-RNA is a more useful index for the prediction of the long-term efficacy of interferon therapy.",
keywords = "Chronic hepatitis C, Hepatic HCV-RNA, Interferon, PCR",
author = "Masaaki Kondo and Katsuaki Tanaka and Masanori Ikeda and Shinju Arata and Satoru Saito and Takashi Sakaguchi and Manabu Morimoto and Takando Fujii and Konomi Mitsui and Hiroshi Okazaki and Masato Hoshino and Hisahiko Sekihara",
year = "1996",
language = "English",
volume = "11",
pages = "236--240",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C

AU - Kondo, Masaaki

AU - Tanaka, Katsuaki

AU - Ikeda, Masanori

AU - Arata, Shinju

AU - Saito, Satoru

AU - Sakaguchi, Takashi

AU - Morimoto, Manabu

AU - Fujii, Takando

AU - Mitsui, Konomi

AU - Okazaki, Hiroshi

AU - Hoshino, Masato

AU - Sekihara, Hisahiko

PY - 1996

Y1 - 1996

N2 - Measurement of serum HCV-RNA is a useful index for evaluating the antiviral effect of interferon therapy in chronic hepatitis C. In the present study, we investigated whether the detection of hepatic HCV-RNA after interferon treatment, using a polymerase chain reaction assay, predicted long-term response to therapy in patients with chronic hepatitis C. Thirty-three patients underwent liver biopsies before and after interferon therapy. Histology and clinical courses were compared after treatment. Before therapy, serum and hepatic HCV-RNA was detected in specimens from 32 (97%) and 33 (100%) patients, respectively. Serum HCV-RNA became undetectable in samples from 22 (67%) patients; however, in 10 of these patients (45%), serum HCV-RNA levels relapsed after therapy. Hepatic HCV-RNA became undetectable in 14 patients after therapy and the serum aminotransferase concentration remained within normal limits during and following (24-92 weeks) therapy in 12 of these patients (86%). All 11 patients with detectable hepatic HCV-RNA also had serum HCV-RNA and elevated aminotransferase concentrations refractory to therapy. The absence of hepatic HCV-RNA at the end of interferon treatment thus predicted a long-term complete response to therapy with a sensitivity of 100%, a specificity of 90% and an accuracy of 94%. We conclude that hepatic rather than serum HCV-RNA is a more useful index for the prediction of the long-term efficacy of interferon therapy.

AB - Measurement of serum HCV-RNA is a useful index for evaluating the antiviral effect of interferon therapy in chronic hepatitis C. In the present study, we investigated whether the detection of hepatic HCV-RNA after interferon treatment, using a polymerase chain reaction assay, predicted long-term response to therapy in patients with chronic hepatitis C. Thirty-three patients underwent liver biopsies before and after interferon therapy. Histology and clinical courses were compared after treatment. Before therapy, serum and hepatic HCV-RNA was detected in specimens from 32 (97%) and 33 (100%) patients, respectively. Serum HCV-RNA became undetectable in samples from 22 (67%) patients; however, in 10 of these patients (45%), serum HCV-RNA levels relapsed after therapy. Hepatic HCV-RNA became undetectable in 14 patients after therapy and the serum aminotransferase concentration remained within normal limits during and following (24-92 weeks) therapy in 12 of these patients (86%). All 11 patients with detectable hepatic HCV-RNA also had serum HCV-RNA and elevated aminotransferase concentrations refractory to therapy. The absence of hepatic HCV-RNA at the end of interferon treatment thus predicted a long-term complete response to therapy with a sensitivity of 100%, a specificity of 90% and an accuracy of 94%. We conclude that hepatic rather than serum HCV-RNA is a more useful index for the prediction of the long-term efficacy of interferon therapy.

KW - Chronic hepatitis C

KW - Hepatic HCV-RNA

KW - Interferon

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=9244236056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9244236056&partnerID=8YFLogxK

M3 - Article

C2 - 8742919

AN - SCOPUS:9244236056

VL - 11

SP - 236

EP - 240

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -